Specialist international clinical development company ERGOMED has opened an office in Russia to support ongoing operations in Russia, Ukraine, Kazakhstan and Belarus – countries believed to have potential for high levels of patient recruitment.
Company CEO Dr Miroslav Reljanović said clinical research in these regions in the firm’s areas of specialisation was of high quality, given the generally high standard of medical training and the concentration of medical expertise in a few centres.
Dr Reljanović continued: “We have been carrying out clinical trials in Eastern Europe for some years now and have successfully integrated our study site management system in Central and Eastern Europe, delivering faster patient recruitment and improved data quality.”
ERGOMED, based in Frankfurt, Germany, offers contract clinical research and co-development partnerships to biotechnology and pharmaceutical companies in the fields of neurology, oncology and immunology.
The company offers standard clinical trial management contracts and also co-development partnerships.